Skip to Main Content

Paper Details

Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples.
Cancer Cytopathol
5
2023
DNA samples, Tier 1/2 mutations, cell, formalin, gene panels, low, low-malignant-cellularity samples, lung cancer, malignant, malignant cell, malignant lymph nodes, malignant-cell, paraffin, patients, tumor
Author NameAffiliation
Ann-Marie PatchQIMR Berghofer Medical Research Institute
Ann-Marie PatchQIMR Berghofer Medical Research Institute
Nicola WaddellQIMR Berghofer Medical Research Institute
Nicola WaddellQIMR Berghofer Medical Research Institute
Sunil R LakhaniUQ Centre for Clinical Research, University of Queensland
Sunil R LakhaniRoyal Brisbane and Women's Hospital
Sunil R LakhaniUQ Centre for Clinical Research, University of Queensland
Sunil R LakhaniRoyal Brisbane and Women's Hospital
Katia NonesQIMR Berghofer Medical Research Institute
Katia NonesUniversity of Queensland
Katia NonesQIMR Berghofer Medical Research Institute
Katia NonesUniversity of Queensland
Peter T SimpsonUQ Centre for Clinical Research, University of Queensland
Peter T SimpsonUQ Centre for Clinical Research, University of Queensland
  • 1 - 14

Datasets

Release 1.2